SCHEMBL22982867

SCHEMBL22982867

CC1(C)C[C@H](CC/C(=N\[S+]([O-])C(C)(C)C)c2ccccn2)CN1C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
RBP4 P02753 2/20 0.35
LMNA P02545 1/20 0.35
PDE10A Q9Y233 1/20 0.33
PLA2G1B P04054 1/20 0.33
ATG4B Q9Y4P1 1/20 0.33
NAMPT P43490 1/20 0.32
EPHX1 P07099 1/20 0.32
EPHX2 P34913 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23006349 0.89 SMN1; SMN2 (0.38) SMN1; SMN2KMT2AMEN1RAB9ANPC1
SCHEMBL28771581 0.85 KDM4E (0.34) SMN1; SMN2KMT2AMEN1RAB9ANPC1
SCHEMBL20584607 0.84 SMN1; SMN2 (0.42) SMN1; SMN2KMT2AMEN1RAB9ANPC1
SCHEMBL21726697 0.84 SMN1; SMN2 (0.42) SMN1; SMN2KMT2AMEN1RAB9ANPC1
SCHEMBL20584606 0.84 SMN1; SMN2 (0.42) SMN1; SMN2KMT2AMEN1RAB9ANPC1
SCHEMBL22983269 0.82 CTNNB1 (0.43) SMN1; SMN2KMT2AMEN1RAB9ANPC1
SCHEMBL28771585 0.82 RBP4 (0.34) SMN1; SMN2KMT2AMEN1RAB9ANPC1
SCHEMBL22982839 0.73 TP53 (0.32) KMT2AKDM4EGAA
SCHEMBL22982842 0.73 TP53 (0.32) KMT2AKDM4EGAA
SCHEMBL22983465 0.73 DPP4 (0.33) KMT2AMEN1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4013759-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2022-06-22 EP disclosed
WO-2021030556-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2021-02-18 WO disclosed